Xia W - Search Results

1

Clinical features and treatment response of solid neuroendocrine breast carcinoma to adjuvant chemotherapy and endocrine therapy.

Zhu Y, Li Q, Gao J, He Z, Sun R, Shen G, Zhang H, Xia W, Xu J. Zhu Y, et al. Among authors: xia w. Breast J. 2013 Jul-Aug;19(4):382-7. doi: 10.1111/tbj.12121. Epub 2013 May 31. Breast J. 2013. PMID: 23721399

2

Prospective study of prognostic value of Raf kinase inhibitory protein and pretreatment plasma Epstein-Barr virus DNA for distant metastasis in locoregionally advanced nasopharyngeal carcinoma.

Li SW, Wang H, Xiang YQ, Zhang HB, Lv X, Xia WX, Zeng MS, Mai HQ, Hong MH, Guo X. Li SW, et al. Head Neck. 2013 Apr;35(4):579-91. doi: 10.1002/hed.23009. Epub 2012 May 18. Head Neck. 2013. PMID: 22605662

3

Favorable prognosis of female patients with nasopharyngeal carcinoma.

Lu X, Wang FL, Guo X, Wang L, Zhang HB, Xia WX, Li SW, Li NW, Qian CN, Xiang YQ. Lu X, et al. Chin J Cancer. 2013 May;32(5):283-8. doi: 10.5732/cjc.012.10058. Epub 2012 Sep 17. Chin J Cancer. 2013. PMID: 22980419 Free PMC article.

4

A novel statistical prognostic score model that includes serum CXCL5 levels and clinical classification predicts risk of disease progression and survival of nasopharyngeal carcinoma patients.

Zhang H, Xia W, Lu X, Sun R, Wang L, Zheng L, Ye Y, Bao Y, Xiang Y, Guo X. Zhang H, et al. Among authors: xia w. PLoS One. 2013;8(2):e57830. doi: 10.1371/journal.pone.0057830. Epub 2013 Feb 28. PLoS One. 2013. PMID: 23469080 Free PMC article.

5

A prognostic model predicts the risk of distant metastasis and death for patients with nasopharyngeal carcinoma based on pre-treatment serum C-reactive protein and N-classification.

Xia WX, Zhang HB, Shi JL, Lu X, Wang L, Ye YF, Cao KJ, Qian CN, Guo X, Xiang YQ. Xia WX, et al. Eur J Cancer. 2013 Jun;49(9):2152-60. doi: 10.1016/j.ejca.2013.03.003. Epub 2013 Apr 6. Eur J Cancer. 2013. PMID: 23571148

6

The impact of baseline serum C-reactive protein and C-reactive protein kinetics on the prognosis of metastatic nasopharyngeal carcinoma patients treated with palliative chemotherapy.

Xia WX, Ye YF, Lu X, Wang L, Ke LR, Zhang HB, Roycik MD, Yang J, Shi JL, Cao KJ, Guo X, Xiang YQ. Xia WX, et al. PLoS One. 2013 Oct 10;8(10):e76958. doi: 10.1371/journal.pone.0076958. eCollection 2013. PLoS One. 2013. PMID: 24130817 Free PMC article.

7

Elevated peripheral blood lymphocyte-to-monocyte ratio predicts a favorable prognosis in the patients with metastatic nasopharyngeal carcinoma.

Jiang R, Cai XY, Yang ZH, Yan Y, Zou X, Guo L, Sun R, Luo DH, Chen QY, Huang PY, Xiang YQ, Lu X, Wang L, Xia WX, Mai HQ, Chen MY. Jiang R, et al. Chin J Cancer. 2015 Jun 10;34(6):237-46. doi: 10.1186/s40880-015-0025-7. Chin J Cancer. 2015. PMID: 26067059 Free PMC article.

8

Safety and efficacy of lobaplatin combined with 5-fluorouracil as first-line induction chemotherapy followed by lobaplatin-radiotherapy in locally advanced nasopharyngeal carcinoma: preliminary results of a prospective phase II trial.

Ke LR, Xia WX, Qiu WZ, Huang XJ, Yang J, Yu YH, Liang H, Liu GY, Ye YF, Xiang YQ, Guo X, Lv X. Ke LR, et al. BMC Cancer. 2017 Feb 15;17(1):134. doi: 10.1186/s12885-017-3080-4. BMC Cancer. 2017. PMID: 28202000 Free PMC article. Clinical Trial.

9

Neoadjuvant chemotherapy followed by concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in locoregionally advanced nasopharyngeal carcinoma: A phase III multicentre randomised controlled trial.

Cao SM, Yang Q, Guo L, Mai HQ, Mo HY, Cao KJ, Qian CN, Zhao C, Xiang YQ, Zhang XP, Lin ZX, Li WX, Liu Q, Qiu F, Sun R, Chen QY, Huang PY, Luo DH, Hua YJ, Wu YS, Lv X, Wang L, Xia WX, Tang LQ, Ye YF, Chen MY, Guo X, Hong MH. Cao SM, et al. Eur J Cancer. 2017 Apr;75:14-23. doi: 10.1016/j.ejca.2016.12.039. Epub 2017 Feb 16. Eur J Cancer. 2017. PMID: 28214653 Clinical Trial.

10

Concurrent chemoradiotherapy with nedaplatin versus cisplatin in stage II-IVB nasopharyngeal carcinoma: an open-label, non-inferiority, randomised phase 3 trial.

Tang LQ, Chen DP, Guo L, Mo HY, Huang Y, Guo SS, Qi B, Tang QN, Wang P, Li XY, Li JB, Liu Q, Gao YH, Xie FY, Liu LT, Li Y, Liu SL, Xie HJ, Liang YJ, Sun XS, Yan JJ, Wu YS, Luo DH, Huang PY, Xiang YQ, Sun R, Chen MY, Lv X, Wang L, Xia WX, Zhao C, Cao KJ, Qian CN, Guo X, Hong MH, Nie ZQ, Chen QY, Mai HQ. Tang LQ, et al. Lancet Oncol. 2018 Apr;19(4):461-473. doi: 10.1016/S1470-2045(18)30104-9. Epub 2018 Feb 28. Lancet Oncol. 2018. PMID: 29501366 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

5,355 results

Search Page

Filters